CelloSelect – A synthetic cellobiose metabolic pathway for selection of stable transgenic CHO cell lines

• Published in: Metabolic engineering 2022-03, Vol.70, p.23-30
• Main Authors: Teixeira, Ana P., Stücheli, Pascal, Ausländer, Simon, Ausländer, David, Schönenberger, Pascal, Hürlemann, Samuel, Fussenegger, Martin
• Format: Article
• Language: English
• Subjects: Animals; antibiotics; biochemical pathways; biopharmaceuticals; Cell Line; cellobiose; Cellobiose - metabolism; Cricetinae; Cricetulus; culture media; erythropoietin; Fermentation; fluorescence; genetically modified organisms; glucose; mammals; metabolic engineering; Metabolic Networks and Pathways; metabolism; monoclonal antibodies; Neurospora crassa; primary energy; Saccharomyces cerevisiae - metabolism; starvation; Synthetic biology; toxicity
• ISSN: 1096-7176; 1096-7184
• DOI: 10.1016/j.ymben.2022.01.001

Current protocols for generating stable transgenic cell lines mostly rely on antibiotic selection or the use of specialized cell lines lacking an essential part of their metabolic machinery, but these approaches require working with either toxic chemicals or knockout cell lines, which can reduce productivity. Since most mammalian cells cannot utilize cellobiose, a disaccharide consisting of two β-1,4-linked glucose molecules, we designed an antibiotic-free selection system, CelloSelect, which consists of a selection cassette encoding Neurospora crassa cellodextrin transporter CDT1 and β-glucosidase GH1-1. When cultivated in glucose-free culture medium containing cellobiose, CelloSelect-transfected cells proliferate by metabolizing cellobiose as a primary energy source, and are protected from glucose starvation. We show that the combination of CelloSelect with a PiggyBac transposase-based integration strategy provides a platform for the swift and efficient generation of stable transgenic cell lines. Growth rate analysis of metabolically engineered cells in cellobiose medium confirmed the expansion of cells stably expressing high levels of a cargo fluorescent marker protein. We further validated this strategy by applying the CelloSelect system for stable integration of sequences encoding two biopharmaceutical proteins, erythropoietin and the monoclonal antibody rituximab, and confirmed that the proteins are efficiently produced in either cellobiose- or glucose-containing medium in suspension-adapted CHO cells cultured in chemically defined media. We believe coupling heterologous metabolic pathways additively to the endogenous metabolism of mammalian cells has the potential to complement or to replace current cell-line selection systems. •A new selection system for generating transgenic cell lines in glucose-free medium.•Transgenic cells are able to utilize cellobiose as glucose source.•Application to generate stable CHO pools expressing model biopharmaceutical proteins.•Combined with PiggyBac transposase expression cassettes allowed competitive product titers.